|
Volumn 99, Issue 3, 2004, Pages 566-567
|
Open-Label Pilot Study of Tetracycline in the Treatment of Primary Biliary Cirrhosis [3]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
ALKALINE PHOSPHATASE;
ANTACID AGENT;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
COLESTYRAMINE;
ORAL CONTRACEPTIVE AGENT;
TETRACYCLINE DERIVATIVE;
URSODEOXYCHOLIC ACID;
ADULT;
AGED;
ALBUMIN BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
AUTOIMMUNITY;
BACTERIUM IDENTIFICATION;
BILIRUBIN BLOOD LEVEL;
CHLAMYDOPHILA PNEUMONIAE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
LETTER;
PATIENT COMPLIANCE;
PILOT STUDY;
PRIMARY BILIARY CIRRHOSIS;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT OUTCOME;
WILCOXON SIGNED RANKS TEST;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
FEMALE;
HUMANS;
LIVER CIRRHOSIS, BILIARY;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
TETRACYCLINE;
|
EID: 1942504429
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1572-0241.2004.04099.x Document Type: Letter |
Times cited : (6)
|
References (2)
|